In the US every year, the number of birth defect cases presenting are ≈ 2,000 with spina bifida, 6,000 with Down’s syndrome, 10,000 with Cerebral palsy and 58,000 with Autism with the total population statistics of the already afflicted estimated at 166,000; 400,000; 500,000 and 1.5 million patients, respectively (while such birth defects present in approximately 3X as many patients located throughout the rest of the westernized countries of the world). A very high percentage of these cases present with either or both urinary and/or fecal incontinence (UI and FI). Incontinence among another segment of the childhood population – those who have attention-deficit hyperactivity disorder (ADHD) – is also a problem that may continue throughout the life of the patient (as noted in the summary of the abstract presented below). The new severe incontinence treatment technology being presented by Precision Medical Devices (PMD) is designed, and expected to optimally treat the severer cases of urinary incontinence (UI), and has a second generation device model that can be sized for children, which can be implanted in a 15 (to 20)-minute same day surgical procedure. The device’s design incorporates features that specifically provide for the use of the technology by caretakers for those patients who are not cognitively or physically capable of activating the control functions themselves. Additionally, the Company is already working on the design of a follow-on device expected to optimally treat fecal incontinence (FI), as well.